For the year ending 2025-12-31, OPK made $606,879K in revenue. -$225,680K in net income. Net profit margin of -37.19%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenues | 606,879 | 713,142 | ||
| Cost of goods and services sold-Service | 307,350 | - | ||
| Cost of goods and services sold-Product | 93,589 | - | ||
| Selling, general and administrative | 223,002 | 304,220 | ||
| Research and development | 124,033 | 105,214 | ||
| Cost of goods and services sold | - | 494,632 | ||
| Contingent consideration | 0 | - | ||
| Amortization of intangible assets | 77,890 | 82,634 | ||
| Gain on sale of assets | 101,576 | 121,493 | ||
| Total costs and expenses | 724,288 | 865,207 | ||
| Operating loss | -117,409 | -152,065 | ||
| Interest income | 14,811 | 8,426 | ||
| Interest expense | 108,462 | 47,465 | ||
| Fair value changes of derivative instruments, net | -429 | -26,161 | ||
| Other Nonoperating Income Expense | -29,875 | 206,903 | ||
| Other income (expense), net | -123,955 | 141,703 | ||
| Loss before income taxes and investment losses | -241,364 | -10,362 | ||
| Income tax benefit (provision) | -15,713 | 42,844 | ||
| Net loss before investment losses | -225,651 | -53,206 | ||
| Loss from investments in investees | -29 | -18 | ||
| Net loss | -225,680 | -53,224 | ||
| Basic EPS | -0.3 | -0.08 | ||
| Diluted EPS | -0.3 | - | ||
| Basic Average Shares | 751,132,891 | 694,019,535 | ||
| Diluted Average Shares | 751,132,891 | - | ||
OPKO HEALTH, INC. (OPK)
OPKO HEALTH, INC. (OPK)